Brianna N. Smith
Affiliations: | 2018- | Cancer Biology | Vanderbilt University, Nashville, TN |
Google:
"Brianna Smith"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Monteith AJ, Ramsey HE, Silver AJ, et al. (2024) Lactate utilization enables metabolic escape to confer resistance to BET inhibition in acute myeloid leukemia. Cancer Research |
| Ramsey HE, Gorska AE, Smith BN, et al. (2023) TLR3 agonism augments CD47 inhibition in acute myeloid leukemia. Haematologica |
| Howard GC, Wang J, Rose KL, et al. (2023) Ribosome subunit attrition and activation of the p53-MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition. Biorxiv : the Preprint Server For Biology |
| Fischer MA, Song Y, Arrate MP, et al. (2022) Selective inhibition of MCL1 overcomes venetoclax-resistance in a murine model of myelodysplastic syndromes. Haematologica |
| Cojocari D, Smith BN, Purkal JJ, et al. (2021) Pevonedistat and azacitidine upregulate NOXA () to increase sensitivity to venetoclax in preclinical models of acute myeloid leukemia. Haematologica |
| Villaume MT, Arrate MP, Ramsey HE, et al. (2021) The delta isoform of PI3K predominates in chronic myelomonocytic leukemia and can be targeted effectively with umbralisib and ruxolitinib. Experimental Hematology |
| Smith BN, Savona M, Komrokji RS. (2019) Challenges in Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN). Clinical Lymphoma, Myeloma & Leukemia. 19: 1-8 |
| Hilton CB, Meggendorfer M, Sekeres MA, et al. (2019) Geno-Clinical Model for the Diagnosis of Bone Marrow Myeloid Neoplasms Blood. 134: 4238-4238 |
| Fischer MA, Arrate M, Childress MA, et al. (2019) Variable Response to BCL2 Inhibition in MDS Is Enhanced across MDS Subtypes with Synergistic Combination of BCL2+MCL1 Inhibition Blood. 134: 2982-2982 |
| Smith BN, Cojocari D, Purkal JJ, et al. (2019) Pevonedistat, a Nedd-8 Activating Enzyme Inhibitor, Upregulates NOXA to Increase Effectiveness of Azacitidine and Venetoclax in Preclinical Models of Acute Myelogenous Leukemia Blood. 134: 1380-1380 |